Agilent price target lowered to $110 from $115 at Barclays

Barclays analyst Luke Sergott lowered the firm’s price target on Agilent to $110 from $115 and keeps an Underweight rating on the shares. The company reported a “decent” quarter with margin outperformance, but management’s commentary “suggests we are in a once-in-a-career cycle in China,” where there is little sign of any demand coming back in the near-term, the analyst tells investors in a research note.